Reactive species and DNA damage in chronic inflammation: Reconciling chemical mechanisms and biological fates

International Journal of Cancer

Volumn 128, Issue 9, 2011, Pages 1999-2009

  Lonkar, Pallavi ^a   Dedon, Peter C ^a  

^a Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

Biomarker; DNA damage; Inflammation; Lipid peroxidation; Macrophage; Metabolism; Neutrophil; Nitric oxide; Superoxide

Indexed keywords

CARBONIC ACID DERIVATIVE; GUANINE; HALOGEN; MALEIC ACID DERIVATIVE; NITRIC OXIDE; NITROSOPEROXYCARBONATE; PEROXYNITRITE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER RISK; CHEMICAL CARCINOGENESIS; CHRONIC INFLAMMATION; DEAMINATION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; DNA ADDUCT; DNA DAMAGE; DNA METABOLISM; GENE MUTATION; GENETIC TRANSFORMATION; HALOGENATION; HUMAN; MACROPHAGE MIGRATION; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR INTERACTION; NERVOUS SYSTEM INFLAMMATION; NEUTROPHIL CHEMOTAXIS; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHAGOCYTE; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CHRONIC DISEASE; DNA DAMAGE; HUMANS; INFLAMMATION; NEOPLASMS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; RISK FACTORS;

EID: 79952474331     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25815     Document Type: Short Survey

References (153)

1. Virchow R. Die krankhaften Geschwulste: 30 Vorlesungen gehalten wahrend des Wintersemesters. Berlin: Hirschwald, 1863. 1862-3.
2. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7. (Pubitemid 36019639)
3. Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005;7:211-17. (Pubitemid 40568680)
4. Hussain SP, Harris CC. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 2007;121:2373-80. (Pubitemid 350022405)
5. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 2010;49:1603-16.
6. Schottenfeld D, Beebe-Dimmer J. Chronic in.ammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin 2006;56:69-83.
7. Thun MJ, Henley SJ, Gansler T. Inflammation and cancer: an epidemiological perspective. Novartis Found Symp 2004;256:6-21.
8. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V. A review of human carcinogens. B. Biological agents. Lancet Oncol 2009;10:321-2.
9. Itzkowitz SH, Yio X. Inflammation and cancer. IV. Colorectal cancer in in.ammatory bowel disease: the role of in.ammation. Am J Physiol Gastrointest Liver Physiol 2004;287:G7-G17. (Pubitemid 38802113)
10. Nelson WG, De Marzo AM, DeWeese TL, Isaacs WB. The role of inflammation in the pathogenesis of prostate cancer. J Urol 2004;172:S6-S11.
11. Whitcomb DC. Inflammation and cancer. V. Chronic pancreatitis and pancreatic cancer. Am J Physiol Gastrointest Liver Physiol 2004;287:G315-G319.
12. Olliver JR, Hardie LJ, Gong Y, Dexter S, Chalmers D, Harris KM, Wild CP. Risk factors, DNA damage, and disease progression in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2005;14:620-5.
13. Farrell RJ, Peppercorn MA. Ulcerative colitis. Lancet 2002;359:331-40. (Pubitemid 34119301)
14. Herszenyi L, Miheller P, Tulassay Z. Carcinogenesis in inflammatory bowel disease. Dig Dis 2007;25:267-9. (Pubitemid 350194181)
15. Seril DN, Liao J, Yang GY, Yang CS. Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis 2003;24:353-62. (Pubitemid 36432628)
16. Mossman BT, Bignon J, Corn M, Seaton A, Gee JB. Asbestos: scientific developments and implications for public policy. Science 1990;247:294-301. (Pubitemid 20046453)
17. Mossman BT, Gee JB. Asbestos-related diseases. N Engl J Med 1989;320:1721-30. (Pubitemid 19163128)
18. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum 1994;61:1-241.
19. Sripa B, Kaewkes S, Sithithaworn P, Mairiang E, Laha T, Smout M, Pairojkul C, Bhudhisawasdi V, Tesana S, Thinkamrop B, Bethony JM, Loukas A, et al. Liver fluke induces cholangiocarcinoma. PLoS Med 2007;4:e201.
20. Asaka M, Takeda H, Sugiyama T, Kato M. What role does Helicobacter pylori play in gastric cancer? Gastroenterology 1997;113:S56-S60.
21. Ebert MP, Yu J, Sung JJ, Malfertheiner P. Molecular alterations in gastric cancer: the role of Helicobacter pylori. Eur J Gastroenterol Hepatol 2000;12:795-8. (Pubitemid 30496706)
22. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related in.ammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009;30:1073-81.
23. Groopman JD, Kensler TW. Role of metabolism and viruses in aflatoxin-induced liver cancer. Toxicol Appl Pharmacol 2005;206:131-7. (Pubitemid 40834307)
24. Mostafa MH, Sheweita SA, O'Connor PJ. Relationship between schistosomiasis and bladder cancer. Clin Microbiol Rev 1999;12:97-111. (Pubitemid 29055955)
25. Badawi AF, Mostafa MH, Probert A, O'Connor PJ. Role of schistosomiasis in human bladder cancer: evidence of association, aetiological factors, and basic mechanisms of carcinogenesis. Eur J Cancer Prev 1995;4:45-59.
26. Nathan C. Points of control in inflammation. Nature 2002;420:846-52. (Pubitemid 36019637)
27. Sawa T, Ohshima H. Nitrative DNA damage in inflammation and its possible role in carcinogenesis. Nitric Oxide 2006;14:91-100. (Pubitemid 43165874)
28. Tan TT, Coussens LM. Humoral immunity, inflammation and cancer. Curr Opin Immunol 2007;19:209-16. (Pubitemid 46356960)
29. Dedon PC, Tannenbaum SR. Reactive nitrogen species in the chemical biology of inflammation. Arch Biochem Biophys 2004;423:12-22. (Pubitemid 38202218)
30. Visconti R, Grieco D. New insights on oxidative stress in cancer. Curr Opin Drug Discov Dev 2009;12:240-5.
31. Ohshima H. Genetic and epigenetic damage induced by reactive nitrogen species: implications in carcinogenesis. Toxicol Lett 2003;140/141:99-104. (Pubitemid 36378927)
32. Ohshima H, Tatemichi M, Sawa T. Chemical basis of inflammation-induced carcinogenesis. Arch Biochem Biophys 2003;417:3-11. (Pubitemid 36960042)
33. Bredt D, Snyder S. Nitric oxide: a physiologic messenger molecule. Neuron 1994;63:175-95.
34. Gross S, Wolin M. Nitric oxide: pathophysiological mechanisms. Ann Rev Physiol 1995;57:737-69.
35. Lancaster J. Nitric oxide in cells. Am Sci 1992;80:248-59.
36. MacMicking J, Xie Q, Nathan C. Nitric oxide and macrophage function. Ann Rev Immunol 1997;15:323-50. (Pubitemid 27169284)
37. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-42.
38. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992;6:3051-64.
39. Thomas DD, Ridnour LA, Isenberg JS, Flores-Santana W, Switzer CH, Donzelli S, Hussain P, Vecoli C, Paolocci N, Ambs S, Colton CA, Harris CC, et al. The chemical biology of nitric oxide: implications in cellular signaling. Free Radic Biol Med 2008;45:18-31.
40. Miwa M, Stuehr DJ, Marletta MA, Wishnok JS, Tannenbaum SR. Nitrosation of amines by stimulated macrophages. Carcinogenesis 1987;8:955-8. (Pubitemid 17122777)
41. Stuehr DJ, Marletta MA. Synthesis of nitrite and nitrate in murine macrophage cell lines. Cancer Res 1987;47:5590-4. (Pubitemid 18046749)
42. Lewis RS, Tamir S, Tannenbaum SR, Deen WM. Kinetic analysis of the fate of nitric oxide synthesized by macrophages in vitro. J Biol Chem 1995;270:29350-5.
43. Mancardi D, Ridnour LA, Thomas DD, Katori T, Tocchetti CG, Espey MG, Miranda KM, Paolocci N, Wink DA. The chemical dynamics of NO and reactive nitrogen oxides: a practical guide. Curr Mol Med 2004;4:723-40. (Pubitemid 39369291)
44. Hughes MN. Chemistry of nitric oxide and related species. Methods Enzymol 2008;436:3-19.
45. van der Vliet A, Eiserich JP, Halliwell B, Cross CE. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity. J Biol Chem 1997;272:7617-25. (Pubitemid 27137309)
46. Hazen SL, Zhang R, Shen Z, Wu W, Podrez EA, MacPherson JC, Schmitt D, Mitra SN, Mukhopadhyay C, Chen Y, Cohen PA, Hoff HF, et al. Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: pathways for monocyte-mediated protein nitration and lipid peroxidation in vivo. Circ Res 1999;85:950-8. (Pubitemid 29534170)
47. Wu W, Chen Y, Hazen SL. Eosinophil peroxidase nitrates protein tyrosyl residues. Implications for oxidative damage by nitrating intermediates in eosinophilic inflammatory disorders. J Biol Chem 1999;274:25933-44.
48. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998;391:393-7. (Pubitemid 28093514)
49. Flores-Santana W, Switzer C, Ridnour LA, Basudhar D, Mancardi D, Donzelli S, Thomas DD, Miranda KM, Fukuto JM, Wink DA. Comparing the chemical biology of NO and HNO. Arch Pharm Res 2009;32:1139-53.
50. Cary SP, Winger JA, Derbyshire ER, Marletta MA. Nitric oxide signaling: no longer simply on or off. Trends Biochem Sci 2006;31:231-9.
51. Lima B, Forrester MT, Hess DT, Stamler JS. S-Nitrosylation in cardiovascular signaling. Circ Res 2010;106:633-46.
52. Holmgren A, Lu J. Thioredoxin and thioredoxin reductase: current research with special reference to human disease. Biochem Biophys Res Commun 2010;396:120-4.
53. Hirst DG, Robson T. Nitrosative stress as a mediator of apoptosis: implications for cancer therapy. Curr Pharm Des 2010;16:45-55.
54. Wink DA, Mitchell JB. Nitric oxide and cancer: an introduction. Free Radic Biol Med 2003;34:951-4. (Pubitemid 36398555)
55. Wink DA, Ridnour LA, Hussain SP, Harris CC. The reemergence of nitric oxide and cancer. Nitric Oxide 2008;19:65-7. (Pubitemid 351970245)
56. Barnes DE, Lindahl T. Repair and genetic consequences of endogenous DNA base damage in mammalian cells. Annu Rev Genet 2004;38:445-76. (Pubitemid 40013735)
57. Reynaud CA, Aoufouchi S, Faili A, Weill JC. What role for AID: mutator, or assembler of the immunoglobulin mutasome? Nat Immunol 2003;4:631-8.
58. Visnes T, Doseth B, Pettersen HS, Hagen L, Sousa MM, Akbari M, Otterlei M, Kavli B, Slupphaug G, Krokan HE. Review. Uracil in DNA and its processing by different DNA glycosylases. Philos Trans R Soc Lond B Biol Sci 2009;364:563-8.
59. Harris RS, Sheehy AM, Craig HM, Malim MH, Neuberger MS. DNA deamination: not just a trigger for antibody diversification but also a mechanism for defense against retroviruses. Nat Immunol 2003;4:641-3. (Pubitemid 36874436)
60. Anant S, Davidson NO. Hydrolytic nucleoside and nucleotide deamination, and genetic instability: a possible link between RNA-editing enzymes and cancer? Trends Mol Med 2003;9:147-52.
61. Chaudhuri J, Alt FW. Class-switch recombination: interplay of transcription, DNA deamination and DNA repair. Nat Rev Immunol 2004;4:541-52.
62. Pham P, Bransteitter R, Goodman MF. Reward versus risk: DNA cytidine deaminases triggering immunity and disease. Biochemistry 2005;44:2703-15. (Pubitemid 40293648)
63. Keegan LP, Leroy A, Sproul D, O'Connell MA. Adenosine deaminases acting on RNA (ADARs): RNA-editing enzymes. Genome Biol 2004;5:209.
64. Hoopengardner B, Bhalla T, Staber C, Reenan R. Nervous system targets of RNA editing identified by comparative genomics. Science 2003;301:832-6. (Pubitemid 36962624)
65. Yonekura SI, Nakamura N, Yonei S, Zhang-Akiyama QM. Generation, biological consequences and repair mechanisms of cytosine deamination in DNA. J Radiat Res (Tokyo) 2009;50:19-26.
66. Turney TA, Wright GA. Nitrous acid and nitrosation. Chem Rev 1959;59:497-513.
67. Shapiro R, Pohl SH. The reaction of ribonucleosides with nitrous acid. Side products and kinetics. Biochemistry 1968;7:448-55.
68. Shapiro R, Yamaguchi H. Nucleic acid reactivity and conformation. I. Deamination of cytosine by nitrous acid. Biochim Biophys Acta 1972;281:501-6.
69. Suzuki T, Yamaoka R, Nishi M, Ide H, Makino K. Isolation and characterization of a novel product, 2′-deoxyoxanosine, from 2′-deoxyguanosine, oligodeoxynucleotide, and calf thymus DNA treated with nitrous acid and nitric oxide. J Am Chem Soc 1996;118:2515-16.
70. Suzuki T, Kanaori K, Tajima K, Makino K. Mechanism and intermediate for formation of 2′-deoxyoxanosine. Nucleic Acids Symp Ser 1997:313-14.
71. Dong M, Dedon PC. Relatively small increases in the steady-state levels of nucleobase deamination products in DNA from human TK6 cells exposed to toxic levels of nitric oxide. Chem Res Toxicol 2006;19:50-7. (Pubitemid 43185462)
72. Dong M, Wang C, Deen WM, Dedon PC. Absence of 2′-deoxyoxanosine and presence of abasic sites in DNA exposed to nitric oxide at controlled physiological concentrations. Chem Res Toxicol 2003;16:1044-55. (Pubitemid 37163210)
73. Pang B, Zhou X, Yu H, Dong M, Taghizadeh K, Wishnok JS, Tannenbaum SR, Dedon PC. Lipid peroxidation dominates the chemistry of DNA adduct formation in a mouse model of in.ammation. Carcinogenesis 2007;28:1807-13. (Pubitemid 47303947)
74. Glaser R, Wu H, Lewis M. Cytosine catalysis of nitrosative guanine deamination and interstrand cross-link formation. J Am Chem Soc 2005;127:7346-58. (Pubitemid 40746019)
75. Lim KS, Huang SH, Jenner A, Wang H, Tang SY, Halliwell B. Potential artifacts in the measurement of DNA deamination. Free Radic Biol Med 2006;40:1939-48. (Pubitemid 43728866)
76. Steenken S, Jovanovic SV. How easily oxidizable is DNA? One-electron reduction potentials of adenosine and guanosine radicals in aqueous solution. J Am Chem Soc 1997;119:617-18. (Pubitemid 27086555)
77. Buettner GR. The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch Biochem Biophys 1993;300:535-43. (Pubitemid 23232908)
78. Shafirovich V, Dourandin A, Huang W, Geacintov NE. The carbonate radical is a site-selective oxidizing agent of guanine in double-stranded oligonucleotides. J Biol Chem 2001;276:24621-6.
79. Yanagawa H, Ogawa Y, Ueno M. Redox ribonucleosides. Isolation and characterization of 5-hydroxyuridine, 8-hydroxyguanosine, and 8-hydroxyadenosine from Torula yeast RNA. J Biol Chem 1992;267:13320-6.
80. Uppu RM, Cueto R, Squadrito GL, Salgo MG, Pryor WA. Competitive reactions of peroxynitrite with 2′-deoxyguanosine and 7,8-dihydro-8-oxo-2′- deoxyguanosine (8-oxodG): relevance to the formation of 8-oxodG in DNA exposed to peroxynitrite. Free Radic Biol Med 1996;21:407-11. (Pubitemid 26271733)
81. Hailer MK, Slade PG, Martin BD, Sugden KD. Nei deficient Escherichia coli are sensitive to chromate and accumulate the oxidized guanine lesion spiroiminodihydantoin. Chem Res Toxicol 2005;18:1378-83. (Pubitemid 41361711)
82. Pouget JP, Frelon S, Ravanat JL, Testard I, Odin F, Cadet J. Formation of modi.ed DNA bases in cells exposed either to gamma radiation or to high-LET particles. Radiat Res 2002;157:589-95. (Pubitemid 34492566)
83. Douki T, Riviere J, Cadet J. DNA tandem lesions containing 8-oxo-7,8-dihydroguanine and formamido residues arise from intramolecular addition of thymine peroxyl radical to guanine. Chem Res Toxicol 2002;15:445-54. (Pubitemid 34241385)
84. Asahi T, Kondo H, Masuda M, Nishino H, Aratani Y, Naito Y, Yoshikawa T, Hisaka S, Kato Y, Osawa T. Chemical and immunochemical detection of 8-halogenated deoxyguanosines at early stage inflammation. J Biol Chem 2010;285:9282-91.
85. Badouard C, Masuda M, Nishino H, Cadet J, Favier A, Ravanat JL. Detection of chlorinated DNA and RNA nucleosides by HPLC coupled to tandem mass spectrometry as potential biomarkers of inflammation. J Chromatogr B Analyt Technol Biomed Life Sci 2005;827:26-31. (Pubitemid 41551592)
86. Masuda M, Suzuki T, Friesen MD, Ravanat JL, Cadet J, Pignatelli B, Nishino H, Ohshima H. Chlorination of guanosine and other nucleosides by hypochlorous acid and myeloperoxidase of activated human neutrophils. Catalysis by nicotine and trimethylamine. J Biol Chem 2001;276:40486-96.
87. Shen Z, Wu W, Hazen SL. Activated leukocytes oxidatively damage DNA, RNA, and the nucleotide pool through halide-dependent formation of hydroxyl radical. Biochemistry 2000;39:5474-82.
88. Henderson JP, Byun J, Williams MV, McCormick ML, Parks WC, Ridnour LA, Heinecke JW. Bromination of deoxycytidine by eosinophil peroxidase: a mechanism for mutagenesis by oxidative damage of nucleotide precursors. Proc Natl Acad Sci USA 2001;98:1631-6. (Pubitemid 32166276)
89. Hazen SL, Heinecke JW. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest 1997;99:2075-81. (Pubitemid 27203762)
90. Bartsch H, Nair J. Oxidative stress and lipid peroxidation-derived DNA-lesions in inflammation driven carcinogenesis. Cancer Detect Prev 2004;28:385-91. (Pubitemid 39568933)
91. Nair U, Bartsch H, Nair J. Lipid peroxidation-induced DNA damage in cancer-prone inflammatory diseases: a review of published adduct types and levels in humans. Free Radic Biol Med 2007;43:1109-20. (Pubitemid 47374441)
92. Blair IA. DNA adducts with lipid peroxidation products. J Biol Chem 2008;283:15545-9.
93. Godschalk RW, Albrecht C, Curfs DM, Schins RP, Bartsch H, van Schooten FJ, Nair J. Decreased levels of lipid peroxidation-induced DNA damage in the onset of atherogenesis in apolipoprotein E deficient mice. Mutat Res 2007;621:87-94. (Pubitemid 47042073)
94. Nair J, De Flora S, Izzotti A, Bartsch H. Lipid peroxidation-derived etheno-DNA adducts in human atherosclerotic lesions. Mutat Res 2007;621:95-105. (Pubitemid 47042074)
95. 6-ethenodeoxyadenosine and 3,N4-ethenodeoxycytidine excretion in thalassemia patients: markers for lipid peroxidation-induced DNA damage. Free Radic Biol Med 2008;44:1863-8.
96. Dechakhamphu S, Pinlaor S, Sitthithaworn P, Nair J, Bartsch H, Yongvanit P. Lipid peroxidation and etheno DNA adducts in white blood cells of liver fluke-infected patients: protection by plasma alpha-tocopherol and praziquantel. Cancer Epidemiol Biomarkers Prev 2010;19:310-18.
97. Nair J, Srivatanakul P, Haas C, Jedpiyawongse A, Khuhaprema T, Seitz HK, Bartsch H. High urinary excretion of lipid peroxidation-derived DNA damage in patients with cancer-prone liver diseases. Mutat Res 2010;683:23-8.
98. Winter CK, Segall HJ, Haddon WF. Formation of cyclic adducts of deoxyguanosine with the aldehydes trans-4-hydroxy-2-hexenal and trans-4-hydroxy-2-nonenal in vitro. Cancer Res 1986;46:5682-6. (Pubitemid 17177969)
99. Douki T, Odin F, Caillat S, Favier A, Cadet J. Predominance of the 1,N2-propano 2′-deoxyguanosine adduct among 4-hydroxy-2-nonenal-induced DNA lesions. Free Radic Biol Med 2004;37:62-70. (Pubitemid 38746651)
100. Pan J, Chung FL. Formation of cyclic deoxyguanosine adducts from omega-3 and omega-6 polyunsaturated fatty acids under oxidative conditions. Chem Res Toxicol 2002;15:367-72. (Pubitemid 34241375)
101. 2-propanodeoxyguanosine adducts in human lung by liquid chromatography-electrospray ionizationtandem mass spectrometry. Chem Res Toxicol 2007;20:565-71.
102. Chung FL, Young R, Hecht SS. Formation of cyclic 1,N2- propanodeoxyguanosine adducts in DNA upon reaction with acrolein or crotonaldehyde. Cancer Res 1984;44:990-5. (Pubitemid 14152780)
103. Pawlowicz AJ, Kronberg L. Characterization of adducts formed in reactions of acrolein with thymidine and calf thymus DNA. Chem Biodivers 2008;5:177-88. (Pubitemid 351201005)
104. 2-propano-2′-deoxyguanosine in the 5′-CpG-3′ DNA sequence. Biochemistry 2007;46:2608-21.
105. 2-[3-Oxo-1(S)-methyl-propyl]-dG DNA adduct hinders interstrand cross-link formation in the 5′-CpG-3′ sequence. Chem Res Toxicol 2006;19:1019-29.
106. 2-2′- deoxyguanosine adducts modulates formation of interstrand crosslinks in the 5′-CpG-3′ sequence. Biochemistry 2008;47:11457-72.
107. Kozekov ID, Nechev LV, Moseley MS, Harris CM, Rizzo CJ, Stone MP, Harris TM. DNA interchain cross-links formed by acrolein and crotonaldehyde. J Am Chem Soc 2003;125:50-61. (Pubitemid 36068643)
108. Stone MP, Cho YJ, Huang H, Kim HY, Kozekov ID, Kozekova A, Wang H, Minko IG, Lloyd RS, Harris TM, Rizzo CJ. Interstrand DNA cross-links induced by alpha,beta-unsaturated aldehydes derived from lipid peroxidation and environmental sources. Acc Chem Res 2008;41:793-804.
109. Minko IG, Kozekov ID, Kozekova A, Harris TM, Rizzo CJ, Lloyd RS. Mutagenic potential of DNA-peptide crosslinks mediated by acrolein-derived DNA adducts. Mutat Res 2008;637:161-72. (Pubitemid 350262811)
110. Sanchez AM, Kozekov ID, Harris TM, Lloyd RS. Formation of inter- and intrastrand imine type DNA-DNA crosslinks through secondary reactions of aldehydic adducts. Chem Res Toxicol 2005;18:1683-90. (Pubitemid 43257750)
111. Budiawan, Eder E. Detection of 1,N(2)-propanodeoxyguanosine adducts in DNA of Fischer 344 rats by an adapted (32)P-post-labeling technique after per os application of crotonaldehyde. Carcinogenesis 2000;21:1191-6.
112. 2-propanodeoxyguanosine adducts. Mutat Res 1999;424:71-81.
113. Chung FL, Pan J, Choudhury S, Roy R, Hu W, Tang MS. Formation of trans-4-hydroxy-2-nonenal- and other enal-derived cyclic DNA adducts from omega-3 and omega-6 polyunsaturated fatty acids and their roles in DNA repair and human p53 gene mutation. Mutat Res 2003;531:25-36. (Pubitemid 37456722)
114. 2- propanodeoxyguanosine adducts as endogenous DNA lesions in rodents and humans. IARC Sci Publ 1999;150:45-54.
115. Zhang S, Villalta PW, Wang M, Hecht SS. Analysis of crotonaldehyde- and acetaldehyde-derived 1,N(2)-propanodeoxyguanosine adducts in DNA from human tissues using liquid chromatography electrospray ionization tandem mass spectrometry. Chem Res Toxicol 2006;19:1386-92.
116. Blair IA. Lipid hydroperoxide-mediated DNA damage. Exp Gerontol 2001;36:1473-81. (Pubitemid 32768725)
117. Lee SH, Blair IA. Oxidative DNA damage and cardiovascular disease. Trends Cardiovasc Med 2001;11:148-55. (Pubitemid 33070339)
118. Marnett LJ. Oxy radicals, lipid peroxidation and DNA damage. Toxicology 2002;181/182:219-22. (Pubitemid 36015702)
119. Marnett LJ. DNA adducts of alpha,beta-unsaturated aldehydes and dicarbonyl compounds. IARC Sci Publ 1994;125:151-63.
120. Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis 2000;21:361-70. (Pubitemid 30137921)
121. Marnett LJ, Burcham PC. Endogenous DNA adducts: potential and paradox. Chem Res Toxicol 1993;6:771-85. (Pubitemid 23351199)
122. Dedon PC. The chemical toxicology of 2-deoxyribose oxidation in DNA. Chem Res Toxicol 2008;21:206-19. (Pubitemid 351222545)
123. Jeong YC, Swenberg JA. Formation of M1G-dR from endogenous and exogenous ROS-inducing chemicals. Free Radic Biol Med 2005;39:1021-9. (Pubitemid 41356594)
124. Zhou X, Taghizadeh K, Dedon PC. Chemical and biological evidence for base propenals as the major source of the endogenous M1dG adduct in cellular DNA. J Biol Chem 2005;280:25377-82. (Pubitemid 40962240)
125. Dedon PC, Plastaras JP, Rouzer CA, Marnett LJ. Indirect mutagenesis by oxidative DNA damage: formation of the pyrimidopurinone adduct of deoxyguanosine by base propenal. Proc Natl Acad Sci USA 1998;95:11113-16. (Pubitemid 28450090)
126. Plastaras JP, Dedon PC, Marnett LJ. Effects of DNA structure on oxopropenylation by the endogenous mutagens malondialdehyde and base propenal. Biochemistry 2002;41:5033-42. (Pubitemid 34298672)
127. Mao H, Schnetz-Boutaud NC, Weisenseel JP, Marnett LJ, Stone MP. Duplex DNA catalyzes the chemical rearrangement of a malondialdehyde deoxyguanosine adduct. Proc Natl Acad Sci USA 1999;96:6615-20. (Pubitemid 29274931)
128. Schnetz-Boutaud N, Daniels JS, Hashim MF, Scholl P, Burrus T, Marnett LJ. Pyrimido[1,2-alpha]purin-10(3H)-one: a reactive electrophile in the genome. Chem Res Toxicol 2000;13:967-70.
129. Schnetz-Boutaud NC, Saleh S, Marnett LJ, Stone MP. Structure of the malondialdehyde deoxyguanosine adduct M1G when placed opposite a two-base deletion in the (CpG)3 frameshift hotspot of the Salmonella typhimurium hisD3052 gene. Adv Exp Med Biol 2001;500:513-16. (Pubitemid 34107047)
130. Wang Y, Schnetz-Boutaud NC, Saleh S, Marnett LJ, Stone MP. Bulge migration of the malondialdehyde OPdG DNA adduct when placed opposite a two-base deletion in the (CpG)3 frameshift hotspot of the Salmonella typhimurium hisD3052 gene. Chem Res Toxicol 2007;20:1200-10. (Pubitemid 47373001)
131. 1dG). J Am Chem Soc 2004;126:10571-81.
132. Riggins JN, Daniels JS, Rouzer CA, Marnett LJ. Kinetic and thermodynamic analysis of the hydrolytic ring-opening of the malondialdehyde-deoxyguanosine adduct, 3-(2′-deoxy-beta-D-erythropentofuranosyl)-pyrimido[1,2-alpha] purin-10(3H)-one. J Am Chem Soc 2004;126:8237-43. (Pubitemid 38878968)
133. Plastaras JP, Riggins JN, Otteneder M, Marnett LJ. Reactivity and mutagenicity of endogenous DNA oxopropenylating agents: base propenals, malondialdehyde, and N(epsilon)-oxopropenyllysine. Chem Res Toxicol 2000;13:1235-42. (Pubitemid 32104003)
134. Halliwell B. Effect of diet on cancer development: is oxidative DNA damage a biomarker? Free Radic Biol Med 2002;32:968-74.
135. Cooke MS, Henderson PT, Evans MD. Sources of extracellular, oxidativelymodified DNA lesions: implications for their measurement in urine. J Clin Biochem Nutr 2009;45:255-70.
136. Evans MD, Olinski R, Loft S, Cooke MS. Toward consensus in the analysis of urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine as a noninvasive biomarker of oxidative stress. FASEB J 2010;24:1249-60.
137. Dechakhamphu S, Yongvanit P, Nair J, Pinlaor S, Sitthithaworn P, Bartsch H. High excretion of etheno adducts in liver fluke-infected patients: protection by praziquantel against DNA damage. Cancer Epidemiol Biomarkers Prev 2008; 17:1658-64.
138. Chen HJ, Kao CF. Effect of gender and cigarette smoking on urinary excretion of etheno DNA adducts in humans measured by isotope dilution gas chromatography/mass spectrometry. Toxicol Lett 2007;169:72-81.
139. Hillestrom PR, Covas MI, Poulsen HE. Effect of dietary virgin olive oil on urinary excretion of etheno-DNA adducts. Free Radic Biol Med 2006;41:1133-8. (Pubitemid 44331572)
140. Chen HJ, Lin GJ, Lin WP. Simultaneous quantiflcation of three lipid peroxidation-derived etheno adducts in human DNA by stable isotope dilution nanoflow liquid chromatography nanospray ionization tandem mass spectrometry. Anal Chem 2010;82:4486-93.
141. Hoberg AM, Otteneder M, Marnett LJ, Poulsen HE. Measurement of the malondialdehyde-2′-deoxyguanosine adduct in human urine by immunoextraction and liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry. J Mass Spectrom 2004;39:38-42. (Pubitemid 38208529)
142. Cooke MS, Olinski R, Loft S. Measurement and meaning of oxidatively modified DNA lesions in urine. Cancer Epidemiol Biomarkers Prev 2008;17:3-14. (Pubitemid 351196268)
143. EESCoOD. Comparative analysis of baseline 8-oxo-7,8-dihydroguanine in mammalian cell DNA, by different methods in different laboratories: an approach to consensus. Carcinogenesis 2002;23:2129-33.
144. Shigenaga MK, Aboujaoude EN, Chen Q, Ames BN. Assays of oxidative DNA damage biomarkers 8-oxo-2′-deoxyguanosine and 8-oxoguanine in nuclear DNA and biological fluids by high-performance liquid chromatography with electrochemical detection. Methods Enzymol 1994;234:16-33.
145. Broedbaek K, Poulsen HE, Weimann A, Kom GD, Schwedhelm E, Nielsen P, Boger RH. Urinary excretion of biomarkers of oxidatively damaged DNA and RNA in hereditary hemochromatosis. Free Radic Biol Med 2009;47:1230-3.
146. Paz-Elizur T, Sevilya Z, Leitner-Dagan Y, Elinger D, Roisman LC, Livneh Z. DNA repair of oxidative DNA damage in human carcinogenesis: potential application for cancer risk assessment and prevention. Cancer Lett 2008;266:60-72.
147. Maynard S, Schurman SH, Harboe C, de Souza-Pinto NC, Bohr VA. Base excision repair of oxidative DNA damage and association with cancer and aging. Carcinogenesis 2009;30:2-10.
148. Friedman JI, Stivers JT. Detection of damaged DNA bases by DNA glycosylase enzymes. Biochemistry 2010;49:4957-67.
149. David SS, O'Shea VL, Kundu S. Base-excision repair of oxidative DNA damage. Nature 2007;447:941-50. (Pubitemid 46975761)
150. Otteneder MB, Knutson CG, Daniels JS, Hashim M, Crews BC, Remmel RP, Wang H, Rizzo C, Marnett LJ. In vivo oxidative metabolism of a major peroxidation-derived DNA adduct, M1dG. Proc Natl Acad Sci USA 2006;103:6665-9.
151. Knutson CG, Akingbade D, Crews BC, Voehler M, Stec DF, Marnett LJ. Metabolism in vitro and in vivo of the DNA base adduct, M(1)G. Chem Res Toxicol 2007;20:550-7.
152. Knutson CG, Skipper PL, Liberman RG, Tannenbaum SR, Marnett LJ. Monitoring in vivo metabolism and elimination of the endogenous DNA adduct, M1dG {3-(2-deoxy-beta-D-erythro-pentofuranosyl)pyrimido[1,2-alpha]purin-10(3H)- one}, by accelerator mass spectrometry. Chem Res Toxicol 2008;21:1290-4.
153. Knutson CG, Rubinson EH, Akingbade D, Anderson CS, Stec DF, Petrova KV, Kozekov ID, Guengerich FP, Rizzo CJ, Marnett LJ. Oxidation and glycolytic cleavage of etheno and propano DNA base adducts. Biochemistry 2009;48:800-9.